Seldar Pharma Inc.
Records under this name other than patents Seldar Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Seldar Pharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,526,719 | Tetrahydroisoquinolin-1-one derivative or salt thereof Lapsed on the fee record Ended Dec 27, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 27, 2024 | From the USPTO record |
| US 8,101,580 | Therapeutic Agent for Irritable Bowel Syndrome Lapsed on the fee record Ended Jan 24, 2024 · High confidence | Lapsed on the fee record | Ended Jan 24, 2024 | High confidence |
| US 10,532,048 | Tetrahydroisoquinolin-1-one derivative or salt thereof Lapsed on the fee record Ended Jan 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2024 | From the USPTO record |
| US 9,150,541 | Tetrahydroisoquinolin-1-one derivative or salt thereof Lapsed on the fee record Ended Oct 6, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 6, 2023 | From the USPTO record |
| US 10,016,410 | Tetrahydroisoquinolin-1-one derivative or salt thereof Lapsed on the fee record Ended Jul 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2022 | From the USPTO record |
| US 8,486,970 | TETRAHYDROISOQUINOLIN-1-ONE Derivative or Salt Thereof Lapsed on the fee record Ended Jul 16, 2021 · High confidence | Lapsed on the fee record | Ended Jul 16, 2021 | High confidence |